MicroRNA dissects out dangerous pancreatic cysts from all the rest

Clinical Cancer Research

Volumn 18, Issue 17, 2012, Pages 4482-4484

  Thomas, Ryan M ^a   Fleming, Jason B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MUCIN; SMALL INTERFERING RNA;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CYST ASPIRATION; CYSTADENOMA; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALIGNANT TRANSFORMATION; MUCINOUS CYSTIC NEOPLASM; NONHUMAN; ONCOGENE K RAS; PANCREAS CANCER; PANCREAS RESECTION; PATIENT ASSESSMENT; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RNA ANALYSIS; TREATMENT DURATION; TREATMENT INDICATION;

HUMANS; MICRORNAS; PANCREATIC CYST; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865758646     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2089     Document Type: Article

References (12)

1. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012;18:4713-24.
2. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, et al. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 2008;207:106-20.
3. Tanaka M, Fernandez-Del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97.
4. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-50.
5. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, Grady WM, et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 2007;11:229-43.
6. Siveke JT, Einwachter H, Sipos B, Lubeseder-Martellato C, Kloppel G, Schmid RM. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007;12:266-79.
7. Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009;69:1095-102.
8. Shen J, Brugge WR, Dimaio CJ, Pitman MB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer 2009;117:217-27.
9. Ito R, Kondo F, Yamaguchi T, Kato K, Sakai Y, Saisho H, et al. Pancreatic intraepithelial neoplasms in the normal appearing pancreas: on their precise relationship with age. Hepatogastroenterology 2008;55:1103-6.
10. Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005;309:1519-24.
11. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8.
12. Yu J, Li A, Hong SM, Hruban RH, Goggins M. MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 2012;18:981-92.